Akebia Therapeutics, Inc. (AKBA)
USD 1.76
(-6.38%)
USD 1.76
(-6.38%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 272.28 Million USD | -20.5% |
| 2022 | 342.48 Million USD | -23.74% |
| 2021 | 449.09 Million USD | 13.26% |
| 2020 | 396.52 Million USD | 5.33% |
| 2019 | 376.44 Million USD | 4.39% |
| 2018 | 360.61 Million USD | 47.24% |
| 2017 | 244.91 Million USD | 5.52% |
| 2016 | 232.09 Million USD | 1843.53% |
| 2015 | 11.94 Million USD | 72.65% |
| 2014 | 6.91 Million USD | 76.91% |
| 2013 | 3.9 Million USD | -20.59% |
| 2012 | 4.92 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 252.73 Million USD | -7.18% |
| 2024 Q2 | 253.95 Million USD | 0.48% |
| 2023 Q2 | 280.51 Million USD | -3.67% |
| 2023 Q3 | 274.42 Million USD | -2.17% |
| 2023 Q4 | 272.28 Million USD | -0.78% |
| 2023 Q1 | 291.21 Million USD | -14.97% |
| 2023 FY | 272.28 Million USD | -20.5% |
| 2022 Q3 | 422.04 Million USD | -8.15% |
| 2022 FY | 342.48 Million USD | -23.74% |
| 2022 Q4 | 342.48 Million USD | -18.85% |
| 2022 Q2 | 459.5 Million USD | -9.77% |
| 2022 Q1 | 509.24 Million USD | 13.39% |
| 2021 Q2 | 437.23 Million USD | 5.4% |
| 2021 Q3 | 465.11 Million USD | 6.38% |
| 2021 Q4 | 449.09 Million USD | -3.44% |
| 2021 Q1 | 414.81 Million USD | 4.61% |
| 2021 FY | 449.09 Million USD | 13.26% |
| 2020 Q2 | 374.91 Million USD | -4.2% |
| 2020 Q4 | 396.52 Million USD | 10.7% |
| 2020 Q1 | 391.35 Million USD | 3.96% |
| 2020 Q3 | 358.18 Million USD | -4.46% |
| 2020 FY | 396.52 Million USD | 5.33% |
| 2019 Q1 | 324.41 Million USD | -10.04% |
| 2019 Q2 | 304.17 Million USD | -6.24% |
| 2019 FY | 376.44 Million USD | 4.39% |
| 2019 Q4 | 376.44 Million USD | 14.89% |
| 2019 Q3 | 327.65 Million USD | 7.72% |
| 2018 Q1 | 245.61 Million USD | 0.29% |
| 2018 FY | 360.61 Million USD | 47.24% |
| 2018 Q4 | 360.61 Million USD | 38.01% |
| 2018 Q3 | 261.28 Million USD | 5.42% |
| 2018 Q2 | 247.85 Million USD | 0.91% |
| 2017 FY | 244.91 Million USD | 5.52% |
| 2017 Q1 | 228.63 Million USD | -1.49% |
| 2017 Q2 | 279.82 Million USD | 22.39% |
| 2017 Q3 | 238.71 Million USD | -14.69% |
| 2017 Q4 | 244.91 Million USD | 2.6% |
| 2016 Q3 | 68.4 Million USD | 9.72% |
| 2016 FY | 232.09 Million USD | 1843.53% |
| 2016 Q4 | 232.09 Million USD | 239.28% |
| 2016 Q2 | 62.34 Million USD | 16.15% |
| 2016 Q1 | 53.67 Million USD | 349.49% |
| 2015 Q1 | 8.85 Million USD | 27.95% |
| 2015 Q4 | 11.94 Million USD | -15.76% |
| 2015 Q3 | 14.17 Million USD | 139.74% |
| 2015 Q2 | 5.91 Million USD | -33.19% |
| 2015 FY | 11.94 Million USD | 72.65% |
| 2014 Q3 | 6.55 Million USD | 36.42% |
| 2014 Q4 | 6.91 Million USD | 5.51% |
| 2014 Q2 | 4.8 Million USD | -22.0% |
| 2014 FY | 6.91 Million USD | 76.91% |
| 2014 Q1 | 6.16 Million USD | 57.58% |
| 2013 Q3 | 2.89 Million USD | 0.0% |
| 2013 FY | 3.9 Million USD | -20.59% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | 3.9 Million USD | 34.9% |
| 2012 FY | 4.92 Million USD | 0.0% |
| 2012 Q4 | 769.19 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 18.908% |
| Alkermes plc | 933.53 Million USD | 70.833% |
| Agenus Inc. | 462.29 Million USD | 41.101% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.278% |
| Aptorum Group Limited | 5.25 Million USD | -5079.771% |
| Ardelyx, Inc. | 130.76 Million USD | -108.229% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 43.083% |
| Bicycle Therapeutics plc | 224.41 Million USD | -21.334% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -109.114% |
| ChromaDex Corporation | 26.5 Million USD | -927.188% |
| Chimerix, Inc. | 19.74 Million USD | -1279.017% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -674.046% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -275.222% |
| CRISPR Therapeutics AG | 346.76 Million USD | 21.479% |
| Precision BioSciences, Inc. | 140.92 Million USD | -93.221% |
| Dyadic International, Inc. | 2.34 Million USD | -11532.96% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1574.273% |
| Fortress Biotech, Inc. | 165.93 Million USD | -64.089% |
| Lantern Pharma Inc. | 2.73 Million USD | -9838.635% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -280.928% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7616.3% |
| Incyte Corporation | 1.59 Billion USD | 82.899% |
| IO Biotech, Inc. | 17.55 Million USD | -1450.963% |
| Jaguar Health, Inc. | 45.86 Million USD | -493.658% |
| Novavax, Inc. | 2.57 Billion USD | 89.415% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -655.136% |
| Opthea Limited | 264.6 Million USD | -2.905% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -108.319% |
| ContextLogic Inc. | 206 Million USD | -32.178% |
| MiMedx Group, Inc. | 96.33 Million USD | -182.661% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -467.005% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7615.946% |
| NextCure, Inc. | 14.99 Million USD | -1715.61% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6636.442% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3977.984% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -482.569% |
| Vaxcyte, Inc. | 167.44 Million USD | -62.609% |
| PDS Biotechnology Corporation | 33.25 Million USD | -718.683% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -15.761% |
| Pharming Group N.V. | 244.07 Million USD | -11.56% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2183.904% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -113.072% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4021.016% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4021.016% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -230.313% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3998.856% |
| Acelyrin, Inc. | 86.35 Million USD | -215.319% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -20857.39% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1793.644% |
| Summit Therapeutics Inc. | 125.25 Million USD | -117.383% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2772.529% |
| Senti Biosciences, Inc. | 52.57 Million USD | -417.941% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -295.898% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -79.713% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -13820.603% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -20287.417% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -20.039% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2806.875% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -19.716% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 44.938% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2394.841% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -889.739% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2149.432% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 44.043% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7216.036% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -620.107% |
| MEI Pharma, Inc. | 8.35 Million USD | -3158.971% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -838.435% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 21.662% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -86.665% |
| Fortress Biotech, Inc. | 165.93 Million USD | -64.089% |
| Precigen, Inc. | 41.64 Million USD | -553.844% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -445.337% |
| AlloVir, Inc. | 45.01 Million USD | -504.881% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -108.91% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -97.596% |
| ImmuCell Corporation | 18.81 Million USD | -1347.179% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -864.667% |
| Onconetix, Inc. | 23.18 Million USD | -1074.619% |
| PureTech Health plc | 125.58 Million USD | -116.818% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2942.313% |
| Elevation Oncology, Inc. | 34.28 Million USD | -694.256% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11036.483% |
| Seer, Inc. | 39.36 Million USD | -591.698% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -340.352% |
| Innoviva, Inc. | 568.55 Million USD | 52.109% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -900.026% |
| ESSA Pharma Inc. | 3.49 Million USD | -7690.6% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3845.003% |
| GT Biopharma, Inc. | 6.63 Million USD | -4005.035% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -2.987% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -224.051% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2685.83% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -902.197% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8340.985% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -269.118% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1622.387% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2366.438% |
| Soligenix, Inc. | 7.27 Million USD | -3642.826% |
| Century Therapeutics, Inc. | 175.94 Million USD | -54.76% |
| Kura Oncology, Inc. | 51.66 Million USD | -427.055% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -124.507% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6488.12% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4016.918% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -7.795% |
| Autolus Therapeutics plc | 263.9 Million USD | -3.175% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2497.663% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -206.419% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -480.582% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 22.833% |
| GRI Bio, Inc. | 2.69 Million USD | -9995.921% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -33532.911% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -775.774% |
| IGM Biosciences, Inc. | 220.17 Million USD | -23.667% |
| INmune Bio, Inc. | 18.86 Million USD | -1343.574% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -6.163% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -922.029% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9916.421% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8200.76% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -365.806% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -183.163% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -2.853% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 66.916% |
| Verastem, Inc. | 71.18 Million USD | -282.506% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -453.699% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -605.809% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -456.46% |
| Histogen Inc. | 5.69 Million USD | -4679.48% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6108.653% |
| Surrozen, Inc. | 8.14 Million USD | -3242.996% |
| Organovo Holdings, Inc. | 2.74 Million USD | -9808.552% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -86654.838% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -384.239% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1549.025% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -432.82% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -32829.645% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -114.864% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2418.007% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -80.455% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10343.075% |
| Apollomics, Inc. | 14.15 Million USD | -1823.882% |
| Amarin Corporation plc | 279.58 Million USD | 2.611% |
| Mesoblast Limited | 188.79 Million USD | -44.221% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1824.562% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -50.611% |
| Synaptogenix, Inc. | 5.52 Million USD | -4824.288% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3995.773% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -60.067% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3081.966% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -15393.802% |
| Exelixis, Inc. | 678.44 Million USD | 59.866% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1042.048% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -65.982% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 54.177% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2449.455% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -16670.406% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -599.481% |
| Gritstone bio, Inc. | 125.91 Million USD | -116.24% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1755.322% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5250.893% |
| Avid Bioservices, Inc. | 275.66 Million USD | 1.226% |
| Insmed Incorporated | 1.66 Billion USD | 83.615% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3438.941% |
| MediWound Ltd. | 27.18 Million USD | -901.534% |
| OmniAb, Inc. | 87.4 Million USD | -211.541% |
| Alector, Inc. | 487.66 Million USD | 44.166% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 32.511% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1377.813% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -609.58% |
| Zai Lab Limited | 240.17 Million USD | -13.369% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 56.784% |
| Aura Biosciences, Inc. | 29.22 Million USD | -831.628% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -186.386% |
| Immunic, Inc. | 25.36 Million USD | -973.348% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -293.274% |
| Veracyte, Inc. | 93.71 Million USD | -190.536% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10305.847% |
| FibroGen, Inc. | 585.72 Million USD | 53.513% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1466.398% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -41593.004% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4714.588% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.444% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3221.383% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -224.066% |
| TG Therapeutics, Inc. | 169.08 Million USD | -61.036% |
| Galecto, Inc. | 5.89 Million USD | -4518.165% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3186.902% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.601% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -844.719% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2057.412% |
| XBiotech Inc. | 8.39 Million USD | -3142.67% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1755.322% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -412.01% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 25.012% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -912.822% |
| Theravance Biopharma, Inc. | 169 Million USD | -61.113% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 77.601% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 45.589% |
| Vaxxinity, Inc. | 30.94 Million USD | -779.935% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 72.001% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4414.71% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 63.463% |
| NexImmune, Inc. | 5.08 Million USD | -5255.519% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -73214.862% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8755.3% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.169% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5182.992% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3552.685% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -935.548% |
| Ainos, Inc. | 7.39 Million USD | -3582.429% |
| Pluri Inc. | 34.11 Million USD | -698.215% |
| Prothena Corporation plc | 135.01 Million USD | -101.669% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -12.005% |
| Celularity Inc. | 102.92 Million USD | -164.539% |
| Rallybio Corporation | 9.43 Million USD | -2785.619% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1013.876% |
| MeiraGTx Holdings plc | 319.99 Million USD | 14.908% |
| Omeros Corporation | 403.25 Million USD | 32.477% |
| Humacyte, Inc. | 114.67 Million USD | -137.438% |
| Immunocore Holdings plc | 228.15 Million USD | -19.341% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5485.374% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -254.818% |
| Blueprint Medicines Corporation | 918.64 Million USD | 70.36% |
| CalciMedica, Inc. | 4.02 Million USD | -6659.856% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1460.205% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -76.646% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -217.288% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 1.982% |
| Pulmatrix, Inc. | 15.96 Million USD | -1605.738% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1626.285% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1006.588% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -8.564% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -436.146% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 77.509% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -756.706% |
| Nutriband Inc. | 1.07 Million USD | -25137.02% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2460.773% |
| Vor Biopharma Inc. | 59.1 Million USD | -360.691% |
| Roivant Sciences Ltd. | 773.95 Million USD | 64.819% |
| Evogene Ltd. | 17.99 Million USD | -1413.546% |
| ProKidney Corp. | 29.21 Million USD | -831.979% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -278.287% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -38523.201% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 85.585% |
| CorMedix Inc. | 11.91 Million USD | -2184.761% |
| BioLineRx Ltd. | 50.7 Million USD | -437.034% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -82.182% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -207.874% |
| Atai Life Sciences N.V. | 49.16 Million USD | -453.857% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -774.051% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1415.906% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -118.466% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4715.83% |
| MediciNova, Inc. | 3.89 Million USD | -6896.872% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1389.616% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18001.288% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7635.688% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 31.459% |
| Biomea Fusion, Inc. | 30.69 Million USD | -787.217% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 89.996% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1605.845% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -772.687% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -363.988% |
| Absci Corporation | 58.3 Million USD | -367.013% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1329.478% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -749.251% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -269.003% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -211.246% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -706.298% |
| Allakos Inc. | 74.79 Million USD | -264.054% |
| Imunon, Inc. | 8.53 Million USD | -3091.95% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1110.111% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -137.159% |
| BioAtla, Inc. | 48.98 Million USD | -455.847% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2449.455% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9698.021% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -108.483% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1815.491% |
| XOMA Corporation | 145.58 Million USD | -87.036% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -708.813% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -296.002% |
| aTyr Pharma, Inc. | 31.59 Million USD | -761.75% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -340.43% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -505.553% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -462.553% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9387.352% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3237.661% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5839.943% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1435.471% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.492% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -67313.124% |
| UroGen Pharma Ltd. | 243.52 Million USD | -11.812% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 15.198% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -9759.905% |
| Orgenesis Inc. | 35.53 Million USD | -666.25% |
| Entera Bio Ltd. | 1.37 Million USD | -19645.25% |
| GH Research PLC | 6.7 Million USD | -3963.379% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3904.221% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1346.335% |
| Xencor, Inc. | 283.55 Million USD | 3.975% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -9019.78% |
| Replimune Group, Inc. | 113.21 Million USD | -140.506% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7147.217% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -163.003% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -67313.124% |
| Portage Biotech Inc. | 4.45 Million USD | -6018.809% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18001.288% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1081.289% |
| OncoCyte Corporation | 49.29 Million USD | -452.329% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6482.06% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -34043.256% |
| Purple Biotech Ltd. | 10 Million USD | -2621.509% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4605.963% |
| scPharmaceuticals Inc. | 57.26 Million USD | -375.519% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2097.986% |
| HilleVax, Inc. | 78.9 Million USD | -245.065% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5291.822% |
| Tharimmune, Inc. | 1.81 Million USD | -14901.658% |
| Genprex, Inc. | 3.25 Million USD | -8267.228% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -904.045% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5100.286% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -132078.155% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -75841.575% |
| OKYO Pharma Limited | 7.42 Million USD | -3569.218% |
| Savara Inc. | 37.19 Million USD | -632.112% |
| Curis, Inc. | 57.61 Million USD | -372.622% |
| Daré Bioscience, Inc. | 26.32 Million USD | -934.138% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -594.613% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -18756.44% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1207.877% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.81% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1178.955% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -3.769% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1179.905% |
| Erasca, Inc. | 78.61 Million USD | -246.373% |
| bluebird bio, Inc. | 424.62 Million USD | 35.876% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -41454.547% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 85.594% |
| DBV Technologies S.A. | 42.8 Million USD | -536.185% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -41454.547% |
| Moderna, Inc. | 4.57 Billion USD | 94.044% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3792.595% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -16342.452% |
| Molecular Templates, Inc. | 31.17 Million USD | -773.527% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1495.12% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 53.701% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -118.696% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -892.408% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -646.892% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -389.417% |
| MacroGenics, Inc. | 154.2 Million USD | -76.572% |
| RenovoRx, Inc. | 4.46 Million USD | -5996.888% |
| Adicet Bio, Inc. | 37.12 Million USD | -633.532% |
| Prime Medicine, Inc. | 60.78 Million USD | -347.988% |
| Aditxt, Inc. | 28.53 Million USD | -854.336% |
| Adagene Inc. | 45.16 Million USD | -502.814% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -150583.726% |
| Quantum-Si incorporated | 26.63 Million USD | -922.444% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 60.966% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -8849.632% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -136.852% |
| SciSparc Ltd. | 1.59 Million USD | -16971.285% |
| Vericel Corporation | 127.7 Million USD | -113.216% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4792.941% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -218.994% |
| Generation Bio Co. | 171.63 Million USD | -58.648% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2257.463% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -550.922% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -7.752% |
| Invivyd, Inc. | 51.71 Million USD | -426.535% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -196.038% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4085.649% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -260.664% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -26568.658% |
| 2seventy bio, Inc. | 310.12 Million USD | 12.201% |
| ADMA Biologics, Inc. | 193.97 Million USD | -40.371% |
| Clene Inc. | 38.95 Million USD | -599.05% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -653.572% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -5.958% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7635.688% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -43.111% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2135.587% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -37.295% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2132.812% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -465.956% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -415.295% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 26.38% |
| Evaxion Biotech A/S | 17.61 Million USD | -1445.55% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -69.197% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -77.749% |
| Trevena, Inc. | 48.26 Million USD | -464.185% |
| Surrozen, Inc. | 8.14 Million USD | -3242.996% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1160.88% |
| Cingulate Inc. | 10.36 Million USD | -2528.033% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -9801.345% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -630.149% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7491.955% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1970.624% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 14.159% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -995.766% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7442.559% |
| Kronos Bio, Inc. | 54.2 Million USD | -402.365% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -478.804% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1096.354% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1256.619% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1100.748% |
| ImmunityBio, Inc. | 1.09 Billion USD | 75.028% |
| Korro Bio, Inc. | 51.75 Million USD | -426.138% |
| Kineta, Inc. | 7.22 Million USD | -3670.244% |
| BioVie Inc. | 9.7 Million USD | -2706.466% |
| Codexis, Inc. | 49.94 Million USD | -445.163% |
| Celularity Inc. | 102.92 Million USD | -164.539% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -182.904% |
| Celcuity Inc. | 51.45 Million USD | -429.226% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -78779.413% |
| Cibus, Inc. | 206.11 Million USD | -32.103% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -541.052% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -933.779% |
| IN8bio, Inc. | 8.77 Million USD | -3004.047% |
| Kodiak Sciences Inc. | 213.59 Million USD | -27.481% |
| Annexon, Inc. | 47.11 Million USD | -477.883% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -204.092% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -182.537% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1889.093% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.541% |
| Eyenovia, Inc. | 19.78 Million USD | -1276.558% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -53.76% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3444.942% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1029.868% |
| Arcellx, Inc. | 339.75 Million USD | 19.857% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2188.511% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -10.893% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2747.297% |
| Moolec Science SA | 13.94 Million USD | -1852.528% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -530.995% |
| Geron Corporation | 146.12 Million USD | -86.336% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -438.841% |
| Royalty Pharma plc | 6.29 Billion USD | 95.676% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -584.551% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -92386.906% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -10967.309% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -43.948% |
| Humacyte, Inc. | 114.67 Million USD | -137.438% |
| Structure Therapeutics Inc. | 29.05 Million USD | -837.272% |
| 89bio, Inc. | 59.96 Million USD | -354.092% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -928.935% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -22666.472% |
| Genelux Corporation | 8.42 Million USD | -3133.812% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3871.514% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -99.743% |
| Notable Labs, Ltd. | 4.42 Million USD | -6050.599% |
| Liquidia Corporation | 73.13 Million USD | -272.292% |
| Mustang Bio, Inc. | 17.61 Million USD | -1445.417% |
| Immunovant, Inc. | 48.95 Million USD | -456.199% |
| Quantum-Si incorporated | 26.63 Million USD | -922.444% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -609.395% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8674.96% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -268.648% |
| Acasti Pharma Inc. | 11.55 Million USD | -2256.035% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1104.398% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9916.421% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -638.365% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -19879.352% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4366.65% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -996.384% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1074.461% |
| PepGen Inc. | 34.63 Million USD | -686.252% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2142.153% |
| United Therapeutics Corporation | 1.18 Billion USD | 76.968% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3798.726% |
| Solid Biosciences Inc. | 38.45 Million USD | -608.011% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3081.966% |
| Immuneering Corporation | 12 Million USD | -2167.48% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -86654.838% |
| Silo Pharma, Inc. | 1.56 Million USD | -17251.189% |
| Belite Bio, Inc | 4.21 Million USD | -6366.089% |
| XOMA Corporation | 145.58 Million USD | -87.036% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11114.456% |
| Bionomics Limited | 10.15 Million USD | -2580.328% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1166.982% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1088.352% |
| uniQure N.V. | 624.01 Million USD | 56.366% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1818.19% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -150583.726% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -59.996% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7327.36% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -104391.467% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3935.675% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3444.942% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1466.398% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2476.523% |
| Altimmune, Inc. | 16.54 Million USD | -1546.134% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 55.92% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1088.352% |
| Compugen Ltd. | 55.77 Million USD | -388.188% |
| Peak Bio, Inc. | 20.75 Million USD | -1212.014% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -146.496% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5387.445% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -72.505% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -262.209% |
| Zura Bio Limited | 21.29 Million USD | -1178.823% |
| PolyPid Ltd. | 17.46 Million USD | -1458.776% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -142.25% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -262.209% |
| Instil Bio, Inc. | 99.8 Million USD | -172.83% |
| argenx SE | 444.95 Million USD | 38.805% |
| Immunome, Inc. | 28.65 Million USD | -850.126% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3166.007% |
| Verona Pharma plc | 58.84 Million USD | -362.75% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1781.345% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1732.472% |
| CervoMed Inc. | 2.59 Million USD | -10389.736% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5486.52% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2037.932% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2484.594% |
| Moolec Science SA | 13.94 Million USD | -1852.528% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11518.798% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -389.766% |
| AnaptysBio, Inc. | 364.28 Million USD | 25.255% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2177.409% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2046.697% |
| NeurAxis, Inc. | 1.91 Million USD | -14135.45% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -599.463% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1942.204% |
| Achilles Therapeutics plc | 19.08 Million USD | -1326.557% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1781.345% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4954.324% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1054.346% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1096.354% |
| Nutriband Inc. | 1.07 Million USD | -25137.02% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -789.885% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1776.418% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 32.144% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -738.503% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1986.635% |
| Palisade Bio, Inc. | 2.73 Million USD | -9841.11% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5083.457% |
| Beam Therapeutics Inc. | 478.38 Million USD | 43.082% |
| Neurogene Inc. | 36.54 Million USD | -644.992% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 31.578% |
| AEON Biopharma, Inc. | 159.88 Million USD | -70.298% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -471.431% |
| Sesen Bio, Inc. | 30.98 Million USD | -778.799% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -948.831% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3481.679% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -39.108% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -41.774% |
| Athira Pharma, Inc. | 30.05 Million USD | -805.902% |
| Vaccinex, Inc. | 5.94 Million USD | -4482.413% |
| HCW Biologics Inc. | 15.05 Million USD | -1708.982% |
| XOMA Corporation | 145.58 Million USD | -87.036% |
| Nektar Therapeutics | 267.04 Million USD | -1.963% |
| Arvinas, Inc. | 644.6 Million USD | 57.759% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1435.471% |
| Merus N.V. | 102.15 Million USD | -166.553% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -86.052% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -186.256% |
| Rezolute, Inc. | 11.73 Million USD | -2220.496% |
| Clene Inc. | 38.95 Million USD | -599.05% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9462.721% |
| BeyondSpring Inc. | 48.26 Million USD | -464.103% |
| Synlogic, Inc. | 32.89 Million USD | -727.746% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1763.32% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -16563.831% |
| Peak Bio, Inc. | 20.75 Million USD | -1212.014% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -329.075% |
| Krystal Biotech, Inc. | 39.71 Million USD | -585.62% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 27.707% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -173.466% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -62823.651% |
| MannKind Corporation | 721.36 Million USD | 62.254% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1119.105% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -12953.068% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -165.413% |
| Gossamer Bio, Inc. | 249.14 Million USD | -9.288% |
| CohBar, Inc. | 1.03 Million USD | -26242.588% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2447.357% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1329.478% |
| Legend Biotech Corporation | 589.93 Million USD | 53.844% |
| Mural Oncology plc | 37.92 Million USD | -617.905% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -105.289% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -11762.641% |
| Disc Medicine, Inc. | 22.87 Million USD | -1090.326% |
| Champions Oncology, Inc. | 28.03 Million USD | -871.24% |
| REGENXBIO Inc. | 262.22 Million USD | -3.836% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -8005.343% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2072.387% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1927.208% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1184.07% |
| Vaxart, Inc. | 34.02 Million USD | -700.256% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1235.443% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -854.325% |
| Cellectis S.A. | 249.57 Million USD | -9.1% |
| Longeveron Inc. | 5.33 Million USD | -5001.874% |
| Repare Therapeutics Inc. | 41.81 Million USD | -551.108% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.679% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -351.045% |
| Revolution Medicines, Inc. | 262.39 Million USD | -3.769% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -12822.971% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3056.585% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2207.321% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1838.952% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12558.624% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.713% |
| Denali Therapeutics Inc. | 122.96 Million USD | -121.438% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4792.941% |
| Veru Inc. | 32.81 Million USD | -729.822% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3863.998% |
| Cingulate Inc. | 10.36 Million USD | -2528.033% |
| Passage Bio, Inc. | 39.26 Million USD | -593.513% |
| Context Therapeutics Inc. | 4.19 Million USD | -6395.838% |
| Exicure, Inc. | 8.54 Million USD | -3085.016% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -822.757% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2496.672% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1135.366% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -67.062% |
| Nuvalent, Inc. | 31.82 Million USD | -755.63% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4180.147% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -332.051% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1412.706% |
| OmniAb, Inc. | 87.4 Million USD | -211.541% |
| Anew Medical, Inc. | 8.24 Million USD | -3203.733% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -611.135% |
| Lipocine Inc. | 2.63 Million USD | -10246.709% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -936.415% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -577.129% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -922.029% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -216.047% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4941.418% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -229.06% |
| Ocugen, Inc. | 23.98 Million USD | -1035.333% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -486.737% |
| Q32 Bio Inc. | 233.12 Million USD | -16.797% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2903.386% |
| Alumis Inc. Common Stock | 53.5 Million USD | -408.929% |
| Equillium, Inc. | 27.95 Million USD | -873.949% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -31.799% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4739.225% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4339.726% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -73.072% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -292.158% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2629.913% |
| Dominari Holdings Inc. | 4.63 Million USD | -5774.585% |
| Edesa Biotech, Inc. | 1.84 Million USD | -14685.053% |
| vTv Therapeutics Inc. | 29.56 Million USD | -820.915% |
| Bio-Techne Corporation | 744.34 Million USD | 63.419% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -115.931% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 20.952% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -571.071% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -840.315% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -194.811% |
| Nkarta, Inc. | 105.6 Million USD | -157.848% |
| BioCardia, Inc. | 4.59 Million USD | -5832.179% |
| Iterum Therapeutics plc | 32.66 Million USD | -733.651% |